Douglas B. Snyder
CIK 1754125 · SVP, General Counsel · last filed 2026-02-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$30.1K
Companies
2
Total Filings
20
Lifetime Open-Market Net
-$1.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IDYA | SVP, General Counsel | 1,039 | $28.98 | $30.1K | $0 | 3 | 2026-02-02 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Legal Officer | 61,848 | $218.96 | $13.54M | -$1.20M | 16 | 2021-04-08 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-12 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +41,304 | -$828.9K | EDGAR |
| 2020-07-08 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −9,804 | -$102.9K | EDGAR |
| 2020-06-08 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-04 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −2,568 | -$21.4K | EDGAR |
| 2020-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −3,876 | -$35.6K | EDGAR |
| 2019-08-21 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −5,424 | -$70.7K | EDGAR |
| 2019-08-14 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −3,756 | -$52.1K | EDGAR |
| 2019-07-11 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −4,968 | -$71.6K | EDGAR |
| 2019-03-05 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +4,968 | -$57.7K | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.